Pyrazol-5-yl-benzamide dual-target fungicides targeting SDH and Qo enzymes

Overview

This research program develops novel dual-target antifungal agents that simultaneously inhibit succinate dehydrogenase (SDH) and coenzyme Qo, two critical targets in commercial fungicides. By combining pharmacophores from both SDH inhibitors (SDHIs) and Qo inhibitors (QoIs) into single molecules, the approach addresses the growing problem of fungicide resistance that limits the effectiveness of single-target drugs. The work builds on prior findings that fluorine-substituted pyrazole amide compounds exhibit strong antifungal activity and aims to extend this foundation by integrating methoxyacrylate-type active groups characteristic of QoIs.

Technical specifications

• Core scaffold: Fluorine-substituted pyrazole amide structure retained from prior validated antifungal compounds
• Fragment-based drug design: Systematic integration of methoxyacrylate motifs and other QoI active groups onto the SDHI core
• Virtual screening: Computational screening against reported 3D protein models of SDH and coenzyme Qo to identify candidates with affinity for both targets
• Synthesis and evaluation cycle: Iterative research loop combining organic synthesis, antifungal activity testing, 3D-QSAR analysis, lead optimization, and resistance risk assessment
• Molecular modeling validation: Preliminary docking studies indicate designed compounds can bind closely to the SDH active site while maintaining suitable interactions at the Qo target

Technology readiness level

The program is at an early-to-mid research stage. Molecular modeling studies have provided initial support for the dual-target design rationale. Future work will establish a candidate compound library, synthesize and screen novel SDH/Qo dual-target inhibitors, and evaluate their antifungal potential and resistance profiles. The goal is to lay the groundwork for the development of next-generation fungicides with reduced resistance risk.